YubNub Social YubNub Social
    #trafficsafety #assaultcar #carviolence #stopcars #notonemore #carextremism #endcarviolence #tennessee #bancarsnow #stopcrashing #pedestriansafety #tragedy #thinkofthechildren #memphis #buy
    Advanced Search
  • Login
  • Register

  • Night mode
  • © 2025 YubNub Social
    About • Directory • Contact Us • Developers • Privacy Policy • Terms of Use • shareasale • FB Webview Detected • Android • Apple iOS • Get Our App

    Select Language

  • English
Install our *FREE* WEB APP! (PWA)
Night mode toggle
Community
New Posts (Home) ChatBox Popular Posts Reels Game Zone Top PodCasts
Explore
Explore
© 2025 YubNub Social
  • English
About • Directory • Contact Us • Developers • Privacy Policy • Terms of Use • shareasale • FB Webview Detected • Android • Apple iOS • Get Our App
Advertisement
Stop Seeing These Ads

Discover posts

Posts

Users

Pages

Blog

Market

Events

Games

Forum

Conservative Voices
Conservative Voices
2 yrs ·Youtube Politics

YouTube
NPR Whistleblower Resigns‚ Smug Elites‚ and Sports Pay Disparity Reality‚ with Andrew Klavan
Like
Comment
Share
Conservative Voices
Conservative Voices
2 yrs ·Youtube Politics

YouTube
This is NPR’s new CEO.
Like
Comment
Share
Conservative Voices
Conservative Voices
2 yrs

Rep. Stefanik Grills Columbia University President at Second House Antisemitism Hearing
Favicon 
www.dailysignal.com

Rep. Stefanik Grills Columbia University President at Second House Antisemitism Hearing

Columbia University and other higher institutions have entirely falled to hold antisemites accountable according to Rep. Elise Stefanik‚ R-N.Y. and other Republican lawmakers. The House Committee on Education and the Workforce held its second hearing on antisemitism on Wednesday. The committee brought in Columbia University President Minouche Shafik and two board of trustee members to answer for the increased amount of antisemitic incidents on campus since the Oct. 7 Hamas terrorist attack on Israel. The first antisemitism hearing held on Dec. 5 led to the eventual resignations of University of Pennsylvania President Liz Magill and Harvard University President Claudine Gay‚ who also faced plagiarism charges. Shafik said in her opening statement that she has a long record of dealing with large‚ diverse organizations in her career and tries to bring that skillset to her job leading the university. “But on Oct. 7 the world changed‚ and so did my focus‚” she said. “Israel was brutally attacked by Hamas terrorists and very soon it became clear that these horrific events would ignite fear and anguish on our campus.” This catastrophe had profound personal implications for many Jews on campus‚ she said‚ as well as for many other Columbia students for whom the attack had implications. She said for these other students the attack was part of a “larger story of Palestinian displacement as well as a humanitarian catastrophe.” The Columbia president said that “trying to reconcile the free speech rights of those who want to protest and the rights of Jewish students to be in an environment free of discrimination and harassment has been the central challenge on our campus and numerous others across the country.” To navigate these issues Shafik said she’s instituted listening sessions for students and staff‚ increased reporting channels for students who may have been victimized‚ created new policies on how to handle demonstrations‚ and created a task force to seek solutions for their challenges. Stefanik pressed Shafik on tenured Columbia Professor Joseph Massad‚ who called the Oct. 7 Hamas attack “awesome” a week after it occurred and has made a number of other anti-Israel statements and comments directed at students. Shafik said that she condemned his statement and that he’s been spoken to about his rhetoric. “Were there any other enforcement action taken&;#63;” Stefanik asked. Shafik responded that he hasn’t made similar comments following the talking to. “Does he need to repeat stating that the massacre of Israeli citizens was awesome&;#63; Does he need to repeat his participation in an unauthorized‚ pro-Hamas demonstration on April 4th&;#63;” Stefanik asked rhetorically. Shafik said that Massad had been removed from his role of chair of the school’s academic review committee. However‚ Stefanik pointed out later in the hearing that his name remains on the website listed as the chair. Shafik wouldn’t confirm that Massad has been removed. Antisemitic professor Joseph Massad still appears on @Columbia’s website as chair of the academic review committee even after university President Shafik claimed he was removed. Her lack of action to combat antisemitism is exactly what has fostered Jewish hate on campus. pic.twitter.com/AM6Kd6xFHt— Rep. Elise Stefanik (@RepStefanik) April 17‚ 2024 The New York congresswoman continued to say that the problem at Columbia seems to be a lack of enforcement. Stefanik then brought up another case of Columbia Professor Mohamed Abdou‚ who was hired after the Oct. 7 attack. He posted on Oct. 11‚ Stefanik said‚ a statement: “Yes‚ I’m with Hamas and Hezbollah and Islamic Jihad.” Abdou also decried‚ Stefanik said‚ what he called “false reports accusing Arabs and Muslims of decapitating the heads of children and being rapists.” Stefanik said there is ample evidence of these incidents taking place “and yet Columbia hired this individual as a professor.” “How does that hiring process work&;#63; Were you aware of those statements before the hiring&;#63;” Stefanik asked. Shafik replied that she shared “repugnance” of those remarks and said that on her watch faculty who make such remarks have consequences. She said that Abdou won’t teach at Columbia again‚ that he’s been terminated‚ and that he is now just grading his students’ papers. Stefanik then asked how the school will change its hiring processes given that Abdou was hired on Shafik’s watch‚ to which Shafik replied that she needs to look for ways to tighten up their standards. Later in the hearing‚ Stefanik brought up that “Mr. Abdou is not grading papers‚ right now he’s on campus at the unsanctioned‚ anti-Israel‚ antisemitic event that is being supported by pro-Hamas activists on campus.” #BREAKING &;quot;Liberated Zone&;quot; on Columbia University Lawn set up by Pro-palestine Protesters demanding Liberation for Gaza and Palestine pic.twitter.com/yCXXX7qAH6— FreedomNews.Tv FNTV (@FreedomNTV) April 17‚ 2024 Stefanik brought up Columbia Law Professor Katherine Franke who said that “all Columbia students who have served in the [Israeli Defense Force] are dangerous and shouldn’t be on campus.” The law professor has been spoken to‚ Shafik said‚ and has also been asked to publicly apologize or clarify her remarks‚ but hasn’t done so yet. “You see the concern her though with the lack of enforcement&;#63; Do you see the concern that speaking to these professors is not enough and it’s sending the message across the university that this is tolerated‚ these antisemitic statements‚” Stefanik said in conclusion to her comments. The post Rep. Stefanik Grills Columbia University President at Second House Antisemitism Hearing appeared first on The Daily Signal.
Like
Comment
Share
Conservative Voices
Conservative Voices
2 yrs ·Youtube Politics

YouTube
Mark Levin Audio Rewind - 4/17/24
Like
Comment
Share
Bikers Den
Bikers Den
2 yrs ·Youtube General Interest

YouTube
One of Arlen Ness creations
Like
Comment
Share
100 Percent Fed Up Feed
100 Percent Fed Up Feed
2 yrs

Maternal RSV Vaccine Stopped During Clinical Trials Due To Safety Concerns‚ FDA Approved Similar Vaccine From Different Manufacturer
Favicon 
100percentfedup.com

Maternal RSV Vaccine Stopped During Clinical Trials Due To Safety Concerns‚ FDA Approved Similar Vaccine From Different Manufacturer

According to an article published by JAMA Network‚ researchers for a maternal vaccine against respiratory syncytial virus (RSV) in infants stopped clinical trials because of an increased risk of preterm births. “A vaccine given during pregnancy that prevents RSV in infants was about 66% effective at protecting against RSV-associated respiratory illness‚ and about 69% effective at protecting against severe disease‚ according to a study in the New England Journal of Medicine‚” Chief Nerd wrote‚ citing JAMA Network. “However‚ the researchers stopped the trial early because of an increased risk of preterm births. Despite the potential risks of maternal RSV vaccination‚ ‘it is essential to weigh this small risk against the proven benefits‚’ the authors of a linked editorial wrote‚ adding that most of the preterm births occurred between 34 and 37 weeks‚” Chief Nerd added. “A vaccine given during pregnancy that prevents RSV in infants was about 66% effective at protecting against RSV-associated respiratory illness‚ and about 69% effective at protecting against severe disease‚ according to a study in the New England Journal of Medicine. However‚… pic.twitter.com/LWaGaCZDY4 — Chief Nerd (@TheChiefNerd) April 14‚ 2024 The Defender noted the halted study was GlaxoSmithKline’s maternal respiratory syncytial virus (RSV) vaccine. “GSK stopped developing a vaccine for pregnant women to protect newborns against syncytial virus (RSV) after identifying an increased risk of preterm births. Pfizer won approval of its nearly identical vaccine after the company said the increased rate of preterm births in its trials was statistically insignificant‚” the outlet wrote. “The results of this trial‚ in which enrollment was stopped early because of safety concerns‚ suggest that the risks of any and severe medically assessed RSV-associated lower respiratory tract disease among infants were lower with the candidate maternal RSV vaccine than with placebo but that the risk of preterm birth was higher with the candidate vaccine‚” an article published in The New England Journal of Medicine stated. “151 more preterm births and 10 more neonatal deaths in the vaccine group‚” Chief Nerd noted. 151 more preterm births and 10 more neonatal deaths in the vaccine group Study Link: https://t.co/8EAafbAkeK pic.twitter.com/qvMQHv5sOa — Chief Nerd (@TheChiefNerd) April 14‚ 2024 The Defender reports: GSK on Thursday provided more details on the clinical trials for its maternal respiratory syncytial virus (RSV) vaccine. The company halted the trials and stopped developing the vaccine in February 2022‚ after identifying an increased risk of preterm birth among vaccinated mothers. The details‚ published in a peer-reviewed article in the New England Journal of Medicine (NEJM)‚ came after GSK previously reported the increased risk and subsequent termination of the trials to regulators‚ GSK’s investors and in the press. According to the NEJM article‚ GSK was unable to identify a mechanism by which the vaccine caused the preterm births. However‚ the company also couldn’t identify any causes other than the vaccine being investigated. Although GSK ended its trials due to the preterm birth safety signal‚ the U.S. Food and Drug Administration (FDA) in 2023 approved Pfizer’s RSV vaccine for pregnant women‚ — even though Pfizer also reported elevated rates of preterm birth among vaccinated women during clinical trials for the vaccine‚ Abrysvo. Pfizer said the rates of preterm birth during the Abrysvo trials were not statistically significant. However‚ the FDA limited approval of the vaccine for women in weeks 32-36 of their pregnancy. The authors of an editorial that accompanied the NEJM article noted that although Pfizer’s FDA-approved maternal RSV vaccine is bivalent and GSK’s RSVPreF3-Mat is monovalent‚ “the vaccines are otherwise similar.” “Excess maternal deaths with @pfizer ABRYSVO [Respiratory Syncytial Virus Vaccine]. Should signal market recall/withdrawal. To be safe‚ women should decline this new injection‚” Dr. Peter McCullough said. Excess maternal deaths with @pfizer ABRYSVO [Respiratory Syncytial Virus Vaccine]. Should signal market recall/withdrawal. To be safe‚ women should decline this new injection. @ChildrensHD @ICANdecide @TexasLindsay_ @TXforVaxChoice @jathorpmfm https://t.co/caT4Vh9q2g https://t.co/kE09M77IXa pic.twitter.com/hLFlGTfqY4 — Peter A. McCullough‚ MD‚ MPH® (@P_McCulloughMD) April 15‚ 2024 Per JAMA Network: The maternal vaccine evaluated in the study is similar to Abrysvo‚ which the US Food and Drug Administration (FDA) approved last year to protect against RSV in infants. The FDA-approved vaccine is currently being monitored for vaccine-associated risks including preterm births. Despite the potential risks of maternal RSV vaccination‚ “it is essential to weigh this small risk against the proven benefits‚” the authors of a linked editorial wrote‚ adding that most of the preterm births occurred between 34 and 37 weeks. So safety concerns put a stop to RSV study for pregnant women but those same safety concerns did not put a stop to the RSV shot being released‚ recommended by CDC‚ and pushed by every OBGYN https://t.co/GXUTWwTeqJ — Daniel Horowitz (@RMConservative) April 15‚ 2024 “Pfizer failed to inform pregnant women participating in its clinical trial for the respiratory syncytial virus (RSV) vaccine that the clinical trial of a similar vaccine by GlaxoSmithKline (GSK) was halted after a safety signal revealed a potential risk of preterm births leading to neonatal deaths‚” The Epoch Times reported last November. Pfizer Failed To Disclose Risks Of Preterm Birth And Neonatal Death To Pregnant Women In RSV Vaccine Trial https://t.co/d95GKqHttG — zerohedge (@zerohedge) November 26‚ 2023 From The Epoch Times: Even though Pfizer knew about the potential safety signal and was studying preterm births as an “adverse event of special interest‚” it continued to enroll women in its clinical trial and did not fully inform participants of the risks the vaccine may pose to their babies—and in some cases‚ provided misleading and contradictory statements‚ according to an investigation by The BMJ. “The BMJ article demonstrates Pfizer’s continued disregard for the law and patient choice‚” attorney Thomas Renz told The Epoch Times in an email. “The entire point of informed consent is to ensure a patient can make a decision based on all available information. Rather than embracing the Nuremberg Code and American laws and regulations‚ Pfizer seems to view informed consent as a barrier to sales—something that causes vaccine hesitancy or drug hesitancy.” “There should have never been a clinical trial in pregnant women studying any injections aimed at RSV in pregnant women‚” Sasha Latypova told The Epoch Times in an email. “Pregnancy and potential to become pregnant is historically the most protected class of human subjects from clinical research because the risks and potential to cause inadvertent harm are too devastating to justify scientific interest in made-up subjects like RSV.” Ms. Latypova is a retired pharmaceutical industry executive with 25 years of experience in pharmaceutical research and development and co-founder of several organizations that work with pharmaceutical companies to design‚ execute‚ collect data‚ and submit clinical trial data to the U.S. Food and Drug Administration (FDA). According to Ms. Latypova‚ what was once considered a harmless cold has since been rebranded as RSV.
Like
Comment
Share
The First - News Feed
The First - News Feed
2 yrs ·Youtube News & Oppinion

YouTube
The Persecution of Donald Trump
Like
Comment
Share
Classic Rock Lovers
Classic Rock Lovers  
2 yrs

Pearl Jam calm down a bit on new single Wreckage
Favicon 
www.loudersound.com

Pearl Jam calm down a bit on new single Wreckage

Pearl Jam have released the third single from their upcoming Dark Matter album‚ out this week
Like
Comment
Share
Classic Rock Lovers
Classic Rock Lovers  
2 yrs

&;quot;Me‚ Bono and Bowie hijacked a Mini and drove to this restaurant where the Edge was to sing him Happy Birthday&;quot;: What happened when we went record shopping with Joe Elliott
Favicon 
www.loudersound.com

&;quot;Me‚ Bono and Bowie hijacked a Mini and drove to this restaurant where the Edge was to sing him Happy Birthday&;quot;: What happened when we went record shopping with Joe Elliott

We gave Def Leppard's Joe Elliott £50
Like
Comment
Share
Classic Rock Lovers
Classic Rock Lovers  
2 yrs

&;quot;I've ripped up my fingers to shreds‚ they bled‚ they blistered&;quot;: Watch Nina DiGregorio's jaw-dropping version of Van Halen's Eruption‚ played on 7-string fretted violin
Favicon 
www.loudersound.com

&;quot;I've ripped up my fingers to shreds‚ they bled‚ they blistered&;quot;: Watch Nina DiGregorio's jaw-dropping version of Van Halen's Eruption‚ played on 7-string fretted violin

Nina DiGregorio spent years preparing for this moment
Like
Comment
Share
Showing 76357 out of 99991
  • 76353
  • 76354
  • 76355
  • 76356
  • 76357
  • 76358
  • 76359
  • 76360
  • 76361
  • 76362
  • 76363
  • 76364
  • 76365
  • 76366
  • 76367
  • 76368
  • 76369
  • 76370
  • 76371
  • 76372
Advertisement
Stop Seeing These Ads

Edit Offer

Add tier








Select an image
Delete your tier
Are you sure you want to delete this tier?

Reviews

In order to sell your content and posts, start by creating a few packages. Monetization

Pay By Wallet

Payment Alert

You are about to purchase the items, do you want to proceed?

Request a Refund